Protocol · Metabolic/Vascular Health
Diabetic Microangiopathy Supportive Care Protocol
Alpha-Lipoic Acid and Benfotiamine are the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Diabetic Microangiopathy Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
7 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Alpha-Lipoic Acid | Amount listed: 600–1,200 mg daily | Antioxidant; reduces oxidative stress; most studied for diabetic neuropathy; may protect small vessels | Not graded yet | ||
| Benfotiamine | Amount listed: 300–600 mg daily | Fat-soluble thiamine derivative; blocks pathways involved in diabetic microvascular damage | Not graded yet | ||
| Supporting stackListed as additions to the core | |||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily | Deficiency common in diabetes; may affect endothelial function and microvascular health | Not graded yet | ||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | Anti-inflammatory; may improve endothelial function and reduce microvascular damage | Not graded yet | ||
| Grape Seed Extract | Amount listed: 150–300 mg daily | Proanthocyanidins protect microvasculature; may improve capillary strength | Not graded yet | ||
| Pycnogenol | Amount listed: 100–200 mg daily | Pine bark extract; antioxidant; studied for diabetic retinopathy and microangiopathy | Not graded yet | ||
| Vitamin B12 | Amount listed: 500–1,000 mcg daily | Often deficient in diabetics on metformin; supports nerve health; may affect homocysteine | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Diabetic Microangiopathy. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Each opens third-party tested products, matched to the dose above where we can.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
How this protocol works
In plain language
Diabetic microangiopathy refers to damage to the small blood vessels (capillaries and small arteries) that occurs as a complication of diabetes. It is the underlying cause of diabetic retinopathy, nephropathy, and contributes to neuropathy.
HOW IT DEVELOPS:
High blood sugar over time damages the walls of small blood vessels through:
- Advanced glycation end products (AGEs)
- Oxidative stress
- Inflammation
- Abnormal blood clotting
- Loss of protective factors
MAJOR MANIFESTATIONS:
Diabetic Retinopathy (Eyes)
- Leading cause of blindness in working-age adults
- Affects 40-80% of diabetics over time
- Stages: non-proliferative to proliferative
Diabetic Nephropathy (Kidneys)
- Leading cause of kidney failure
- Affects 20-40% of diabetics
- Early sign: microalbuminuria (small amounts of protein in urine)
Diabetic Neuropathy (Nerves)
- Affects up to 50% of diabetics
- Causes numbness, pain, weakness in extremities
- Can affect autonomic functions (heart rate, digestion)
PREVENTION IS KEY:
1. Tight glucose control (most important!)
2. Blood pressure control (<130/80)
3. Lipid management
4. ACE inhibitors/ARBs (kidney protection)
5. Regular screening (eye exams, urine tests, foot checks)
CRITICAL: Blood sugar control is the MOST IMPORTANT factor. Supplements are supportive, not substitutes for glycemic control.
Alpha-lipoic acid* is well-studied for diabetic neuropathy.
Benfotiamine* blocks pathways that cause microvascular damage.
Grape seed and pycnogenol* may support capillary health.
Expected timeline: Prevention and slowing of progression require lifelong diabetes management. Supplements may provide modest additional protection.